Molecular Therapy

SJR Rank #461H-index: 233SJR: 3.814Best quartile: Q1APC: US$4,500
Journal website: aims, scope and author guidelines
Publisher

Cell Press

Country

United States

Type

journal

SJR by Edition

2022202501234

Subject Categories

  • Drug DiscoveryQ1
  • GeneticsQ1
  • Medicine (miscellaneous)Q1
  • Molecular BiologyQ1
  • Molecular MedicineQ1
  • PharmacologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Virus-based gene therapy researchRNA Interference and Gene DeliveryCRISPR and Genetic EngineeringViral Infectious Diseases and Gene Expression in InsectsCAR-T cell therapy researchCancer Research and TreatmentsImmunotherapy and Immune ResponsesAdvanced biosensing and bioanalysis techniquesAnimal Genetics and ReproductionMuscle Physiology and Disorders

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs02505007501000

Documents per Year

202220250150300450600

Detailed Information

ISSN

1525-0024, 1525-0016

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

8.04

References per Document

60.53

Coverage

2000-2026

Scope

Molecular Therapy is the leading international journal for research on the development of molecular and cellular therapeutics to correct genetic and acquired diseases, including but not limited to research on gene transfer and editing, vector development and design, stem cell manipulation, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials.

Metrics from SCImago Journal Rank 2025. View on SCImago